Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Katie Jeffery and Philippa Matthews.
Katie Jeffery
Connection Strength
1.819
Philippa Matthews
  1. Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status. Clin Microbiol Infect. 2021 Oct; 27(10):1516.e7-1516.e14.
    View in: PubMed
    Score: 0.237
  2. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. Nat Commun. 2021 03 29; 12(1):1951.
    View in: PubMed
    Score: 0.234
  3. SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020. Euro Surveill. 2020 10; 25(42).
    View in: PubMed
    Score: 0.226
  4. Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory Samples. J Clin Microbiol. 2019 12 23; 58(1).
    View in: PubMed
    Score: 0.215
  5. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort. BMC Infect Dis. 2018 Sep 14; 18(1):461.
    View in: PubMed
    Score: 0.196
  6. Oxford Screening CSF and Respiratory samples ('OSCAR'): results of a pilot study to screen clinical samples from a diagnostic microbiology laboratory for viruses using Illumina next generation sequencing. BMC Res Notes. 2018 Feb 09; 11(1):120.
    View in: PubMed
    Score: 0.189
  7. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers. Clin Infect Dis. 2021 08 02; 73(3):e699-e709.
    View in: PubMed
    Score: 0.060
  8. Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals. J Infect. 2021 10; 83(4):473-482.
    View in: PubMed
    Score: 0.060
  9. An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status. Clin Infect Dis. 2021 Jul 03.
    View in: PubMed
    Score: 0.060
  10. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat Commun. 2021 04 06; 12(1):2055.
    View in: PubMed
    Score: 0.059
  11. Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections. BMC Infect Dis. 2021 Feb 18; 21(1):187.
    View in: PubMed
    Score: 0.058
  12. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. N Engl J Med. 2021 02 11; 384(6):533-540.
    View in: PubMed
    Score: 0.058
  13. Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study. Elife. 2020 08 21; 9.
    View in: PubMed
    Score: 0.056
  14. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020; 5:181.
    View in: PubMed
    Score: 0.056
  15. Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel. Wellcome Open Res. 2020; 5:139.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.